Pyxis Oncology, Inc. (PYXS) Operating cash flow 2020–2025
Pyxis Oncology, Inc. (PYXS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$63.5MFY2025 · since FY2020: -$10.1M → -$63.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.5M | -10.1% |
| FY2024 | -$57.7M | +18.4% |
| FY2023 | -$70.7M | +20.8% |
| FY2022 | -$89.3M | -152.9% |
| FY2021 | -$35.3M | -250.3% |
| FY2020 | -$10.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating marginPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →